María del Mar
Castellanos Rodrigo
Profesora Titular de Universidad
Hospital Universitario de la Princesa
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (27)
2023
-
Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial
JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788
2022
-
Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology
Neurologia, Vol. 37, Núm. 1, pp. 61-72
-
Thrombosis with thrombocytopenia syndrome following adenovirus vector-based vaccines to prevent COVID-19: Epidemiology and clinical presentation in Spain
Neurologia
2021
-
Recommendations of the Spanish Society of Neurology for the prevention of stroke. Interventions on lifestyle and air pollution
Neurologia, Vol. 36, Núm. 5, pp. 377-387
-
Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group
Neurologia, Vol. 36, Núm. 6, pp. 462-471
-
Stroke prevention in patients with type 2 diabetes or prediabetes. Recommendations from the Cerebrovascular Diseases Study Group, Spanish Society of Neurology
Neurologia, Vol. 36, Núm. 4, pp. 305-323
-
Time Trends in Intracerebral Hemorrhage Associated with Oral Anticoagulation and Its Risks Factors in Spain from 2008 to 2015
European Neurology, Vol. 84, Núm. 1, pp. 16-21
2019
-
The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study
European Journal of Neurology, Vol. 26, Núm. 2, pp. 230-237
2018
-
Factors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study
Revista Clinica Espanola, Vol. 218, Núm. 7, pp. 327-335
2017
-
Clinical profile and satisfaction with anticoagulated treatment in patients with non-valvular atrial fibrillation attended in internal medicine and neurology departments of Spain
Revista de Neurologia, Vol. 65, Núm. 8, pp. 361-367
2014
-
Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment
Neurologia
-
Oct-2 transcription factor binding activity and expression up-regulation in rat cerebral ischaemia is associated with a diminution of neuronal damage in vitro
NeuroMolecular Medicine, Vol. 16, Núm. 2, pp. 332-349
-
The high-mobility group I-Y transcription factor is involved in cerebral ischemia and modulates the expression of angiogenic proteins
Neuroscience, Vol. 269, pp. 112-130
2011
-
Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke
Stroke, Vol. 42, Núm. 10, pp. 2813-2818
2008
-
Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment
Disease Markers, Vol. 25, Núm. 3, pp. 181-188
-
Body temperature and response to thrombolytic therapy in acute ischaemic stroke
European Journal of Neurology, Vol. 15, Núm. 12, pp. 1384-1389
-
High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA
Stroke, Vol. 39, Núm. 7, pp. 2006-2010
-
Marcadores moleculares asociados a signos precoces de isquemia en tomografía computarizada cerebral
Neurologia, Vol. 23, Núm. 4, pp. 220-225
2007
-
Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke
Stroke, Vol. 38, Núm. 1, pp. 90-95
-
Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study
Stroke, Vol. 38, Núm. 6, pp. 1855-1859